NAUT
Nautilus Biotechnology, Inc.Company with tickers: NAUT
CIK
1808805
CUSIP
63909J108
Shares Outstanding
127,078,855
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $16,124,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Research & Development | $9,707,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Operating Income | — | ||||
| Net Income | $-14,697,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| EPS (Basic) | $-0.12 | USD/shares | 2026-03-31 | 10-Q | 2026-04-28 |
| EPS (Diluted) | $-0.12 | USD/shares | 2026-03-31 | 10-Q | 2026-04-28 |